BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 6106520)

  • 21. [On the mode of action of antirheumatic drugs (author's transl)].
    Müller AE; Thiele HG
    Immun Infekt; 1976 Feb; 4(1):14-22. PubMed ID: 815165
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adverse reactions to the principal drugs used in rheumatoid arthritis--a review.
    Franchimont P; Heynen G; Hauwaert CH
    J Rheumatol Suppl; 1978; 4():85-92. PubMed ID: 282449
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum amyloid A protein during the treatment of rheumatoid arthritis with second-line drugs.
    Grindulis KA; Scott DL; Robinson MW; Bacon PA; McConkey B
    Br J Rheumatol; 1985 May; 24(2):158-63. PubMed ID: 2859902
    [TBL] [Abstract][Full Text] [Related]  

  • 24. How reliable is ESR as a measure of disease activity in rheumatoid arthritis treated with hydroxychloroquine?
    Dixon JS; Greenwood M; Bird HA
    Clin Rheumatol; 1988 Jun; 7(2):262-6. PubMed ID: 2901304
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of azathioprine, cyclophosphamide, and gold in treatment of rheumatoid arthritis.
    Currey HL; Harris J; Mason RM; Woodland J; Beveridge T; Roberts CJ; Vere DW; Dixon AS; Davies J; Owen-Smith B
    Br Med J; 1974 Sep; 3(5934):763-6. PubMed ID: 4606370
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proceedings: Trial of azathioprine, cyclophosphamide, and gold in rheumatoid arthritis.
    Woodland J; Mason RM; Harris J; Dixon AS; Currey HL; Brownjohn AM; Davies J; Owen-Smith BD
    Ann Rheum Dis; 1974 Jul; 33(4):399-401. PubMed ID: 4606944
    [No Abstract]   [Full Text] [Related]  

  • 27. [The basic therapy of rheumatoid arthritis].
    Sigidin IaA
    Ter Arkh; 1988; 60(4):148-54. PubMed ID: 2899360
    [No Abstract]   [Full Text] [Related]  

  • 28. Disease-modifying drugs for progressive rheumatoid arthritis.
    Bunch TW; O'Duffy JD
    Mayo Clin Proc; 1980 Mar; 55(3):161-79. PubMed ID: 6766523
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Current status of drug therapy in chronic polyarthritis].
    Seitz M
    Ther Umsch; 1991 Sep; 48(9):613-23. PubMed ID: 1683020
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Chlorbutin, azathioprine, D-penicillamine and dekaris (levamisole) in the treatment of rheumatoid arthritis. Comparative analysis of their effect on the indices of disease activity and progression].
    Krel' AA; Kanevskaia MZ; Rashchupkina ZP; Bolotin EV; Chichasova NV
    Ter Arkh; 1982; 54(6):82-92. PubMed ID: 7112429
    [No Abstract]   [Full Text] [Related]  

  • 31. Levamisole - a possible alternative to gold and penicillamine in the longterm treatment of rheumatoid arthritis?
    Capell HA; Hunter JA; Rennie JA; Murdoch RM
    J Rheumatol; 1981; 8(5):730-40. PubMed ID: 7310774
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison between penicillamine and sulphasalazine in rheumatoid arthritis: Leeds-Birmingham trial.
    Neumann VC; Grindulis KA; Hubball S; McConkey B; Wright V
    Br Med J (Clin Res Ed); 1983 Oct; 287(6399):1099-102. PubMed ID: 6138116
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Old and new drugs used in rheumatoid arthritis: a historical perspective. Part 1: the older drugs.
    Case JP
    Am J Ther; 2001; 8(2):123-43. PubMed ID: 11304666
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Remission-inducing drugs in rheumatoid arthritis.
    Anastassiades TP
    Can Med Assoc J; 1980 Feb; 122(4):405-15. PubMed ID: 6768438
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rheumatoid arthritis: a pharmacologic overview.
    Pinals RS
    Am Fam Physician; 1988 Mar; 37(3):145-52. PubMed ID: 2894754
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A rheumatological dilemma: is it possible to modify the course of rheumatoid arthritis? Can we answer the question?
    Pullar T; Capell HA
    Ann Rheum Dis; 1985 Feb; 44(2):134-40. PubMed ID: 2858180
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-rheumatic drugs and joint damage in rheumatoid arthritis.
    Scott DL; Dawes PT; Fowler PD; Grindulis KA; Shadforth M; Bacon PA
    Q J Med; 1985 Jan; 54(213):49-59. PubMed ID: 3919415
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early versus delayed treatment in patients with recent-onset rheumatoid arthritis: comparison of two cohorts who received different treatment strategies.
    Lard LR; Visser H; Speyer I; vander Horst-Bruinsma IE; Zwinderman AH; Breedveld FC; Hazes JM
    Am J Med; 2001 Oct; 111(6):446-51. PubMed ID: 11690569
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Comparative effectiveness of the basic drugs used in rheumatoid arthritis (long-term randomized study)].
    Tsvetkova ES
    Ter Arkh; 1985; 57(8):40-3. PubMed ID: 3934779
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Critical evaluation of rheumatism therapy. Basic drugs].
    Meyer W
    Ther Ggw; 1975 Dec; 114(12):2029-42. PubMed ID: 1198356
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.